SCHEMBL19863517

SCHEMBL19863517

c1cc(-n2c3ccccc3c3ccccc32)cc(-n2c3ccccc3c3ccc4c5ccccc5n(-c5cccc(-n6c7ccccc7c7ccccc76)c5)c4c32)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.59
ATM Q13315 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
ALKBH5 Q6P6C2 1/20 0.40
FTO Q9C0B1 1/20 0.40
DUSP3 P51452 1/20 0.39
GPR3 P46089 1/20 0.37
MAPK8 P45983 2/20 0.36
MAPK9 P45984 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
FOLH1 Q04609 1/20 0.35
POLB P06746 2/20 0.35
CYP19A1 P11511 1/20 0.35
ALDH1A1 P00352 3/20 0.34
PTPN1 P18031 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12691151 0.96 L3MBTL1 (0.67) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL2754634 0.94 L3MBTL1 (0.63) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL15128411 0.94 L3MBTL1 (0.61) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL10027624 0.91 L3MBTL1 (0.60) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL12690941 0.90 L3MBTL1 (0.69) KDM4EATML3MBTL1MAPK8MAPK9
SCHEMBL17689873 0.90 L3MBTL1 (0.69) KDM4EATML3MBTL1MAPK8MAPK9
SCHEMBL12456522 0.90 KDM4E (0.48) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL57391 0.89 L3MBTL1 (0.73) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL29351958 0.89 L3MBTL1 (0.73) KDM4EATML3MBTL1ALKBH5FTO
SCHEMBL29371952 0.89 L3MBTL1 (0.73) KDM4EATML3MBTL1ALKBH5FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device SAMSUNG SDI CO., LTD. (KR) 2020-03-24 US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device OXER1, OR10J3, OR51E2 KDM4E 4718/4885ATM 4443/4885L3MBTL1 4752/4885
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OXER1, OR10J3, OR51E2 KDM4E 4718/4885ATM 4443/4885L3MBTL1 4752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.